Evolution Advisers’s Elevance Health ELV Stock Holding History

Evolution Advisers’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$108K	Buy	281 +45	+19%	+$16.7K	0.04%	77
2026 Q1	$69K	Hold	236	–	–	0.03%	77
2025 Q4	$82K	Hold	236	–	–	0.04%	69
2025 Q3	$78K	Hold	236	–	–	0.04%	73
2025 Q2	$91K	Hold	236	–	–	0.04%	65
2025 Q1	$102K	Hold	236	–	–	0.05%	61
2024 Q4	$87K	Hold	236	–	–	0.05%	68
2024 Q3	$122K	Hold	236	–	–	0.07%	48
2024 Q2	$127K	Sell	236 -114	-33%	-$60.3K	0.07%	47
2024 Q1	$182K	Sell	350 -10	-3%	-$4.97K	0.11%	40
2023 Q4	$172K	Sell	360 -11	-3%	-$5.09K	0.11%	39
2023 Q3	$161K	Sell	371 -9	-2%	-$4.08K	0.12%	36
2023 Q2	$168K	Buy	380 +227	+148%	+$105K	0.12%	39
2023 Q1	$70K	Hold	153	–	–	0.05%	55
2022 Q4	$78K	Sell	153 -5	-3%	-$2.54K	0.06%	50
2022 Q3	$71K	Hold	158	–	–	0.06%	48
2022 Q2	$76K	Hold	158	–	–	0.06%	51
2022 Q1	$77K	Hold	158	–	–	0.06%	53
2021 Q4	$73K	Buy	+158	New	+$66.5K	0.05%	46

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Evolution Advisers's ELV Position: Q2 2026 in Review

Evolution Advisers increased its Elevance Health (ELV) stake by 19% in Q2 2026, buying an estimated $16.7K and bringing the position to 281 shares worth $108K. The position accounts for 0.04% of the portfolio, ranked #77.

Evolution Advisers first reported a position in ELV in Q4 2021 and has held it in 19 quarters since. The position peaked at $182K in Q1 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Evolution Advisers held 281 shares of Elevance Health worth $108K as of Q2 2026.
Evolution Advisers bought 45 Elevance Health shares in Q2 2026, an estimated $16.7K.
Elevance Health made up 0.04% of Evolution Advisers's portfolio in Q2 2026, its #77 holding.
Evolution Advisers first reported a position in Elevance Health in Q4 2021 and has held it in 19 quarters since.
Evolution Advisers's Elevance Health position peaked at $182K in Q1 2024.
1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Evolution Advisers's 13F filing for Q2 2026, filed 31 Jul 2026.